By Samuel Ouma
Kenya has now administered the Covid-19 vaccine to 370,000 people, announced the Ministry of Health.
The country is aiming to have 16 million people inoculated by June 2022.
In early March, Kenya received the first batch of 1.02 million doses of AstraZeneca-Oxford vaccine from the global COVAX initiative meant for the low and middle-income countries.
Minister of Health Mutahi Kagwe said the Ministry is prioritizing medical workers, teachers, police officers, the elderly, and those with underlying medical conditions.
According to President Uhuru Kenyatta, the second batch of the vaccine is expected by the end of April.
Out of the 370,000 people, 279 had severe effects, with seven others experiencing severe symptoms.
Unfortunately, a pregnant woman died after receiving the jab.
A probe has been launched by Kenya’s Pharmacy and Poisons Board (PPB) to unveil what might have killed her.
Deputy Director at PPB Dr. Peter Ikamati said the board would release the report on the incident on Friday.
“What we can say is it was a misreport, an expectant female got a miscarriage, it happened within period of being given vaccine. Miscarriage could have happened, it does not have to be linked to the shot,” he said.